HTG Molecular
HTG Molecular, OmiCure Partner to Use Transcriptome Panel to Guide Cancer Therapy
Samples from OmiCure will be sent to HTG's laboratory for testing with its transcriptome panel, and the data will be analyzed by OmiCure.
In Brief This Week: Labcorp, Lucid Diagnostics, Seegene, Babson Diagnostics, Danaher, More
News items for the in vitro diagnostics industry for the week of May 8, 2022.
In Brief This Week: Babson Diagnostics, HTG Molecular Diagnostics, Angle, Mainz Biomed, and More
News items for the in vitro diagnostics industry for the week of March 14, 2022.
In Brief This Week: MDxHealth, Co-Diagnostics, HTG Molecular Diagnostics, Immunovia, and More
News items for the in vitro diagnostics industry for the week of Nov. 8, 2021.
HTG Molecular Diagnostics Q2 Revenues up 5 Percent as Pandemic Pressures Ease
The company said that it saw growing demand for RUO sample processing services and consumables as development activities among its customer base picked up speed.
Nov 23, 2020
HTG Molecular Completes 1-For-15 Reverse Stock Split
Jun 26, 2020